• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于肽功能化硅纳米线基底的胰腺癌循环肿瘤细胞捕获和生物释放。

Capture and biological release of circulating tumor cells in pancreatic cancer based on peptide-functionalized silicon nanowire substrate.

机构信息

Department of Oncology, The Central Hospital of Wuhan, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China,

Cancer Center, Renmin Hospital, Wuhan University, Wuhan, China,

出版信息

Int J Nanomedicine. 2018 Dec 24;14:205-214. doi: 10.2147/IJN.S187892. eCollection 2019.

DOI:10.2147/IJN.S187892
PMID:30636873
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6307685/
Abstract

BACKGROUND

Efficient and precise circulating tumor cells' (CTCs) capture and release with minimal effect on cell viability for CTCs' analysis are general requirements of CTCs' detection device in clinical application. However, these two essential factors are difficult to be achieved simultaneously.

METHODS

In order to reach the aforementioned goal, we integrated multiple strategies and technologies of staggered herringbone structure, nanowires' substrate, peptides, enzymatic release, specific cell staining, and gene sequencing into microfluidic device and the sandwich structure peptide-silicon nanowires' substrate was termed as Pe-SiNWS.

RESULTS

The Pe-SiNWS demonstrated excellent capture efficiency (95.6%) and high release efficiency (92.6%). The good purity (28.5%) and cell viability (93.5%) of CTCs could be obtained through specific capture and biological release by using Pe-SiNWS. The good purity of CTCs facilitated precise and quick biological analysis, and five types of KRAS mutation were detected in 16 pancreatic cancer patients but not in healthy donors.

CONCLUSION

The results proved that the effective capture, minor damage release, and precise analysis of CTCs could be realized simultaneously by our novel strategy. The successful clinical application indicated that our work was anticipated to open up new opportunities for the design of CTC microfluidic device.

摘要

背景

高效、精确地捕获循环肿瘤细胞(CTCs),同时最大限度地减少对细胞活力的影响,这是临床应用中 CTC 检测设备的普遍要求。然而,这两个关键因素很难同时实现。

方法

为了达到上述目标,我们将交错齿形结构、纳米线基底、肽、酶释放、特定细胞染色和基因测序等多种策略和技术集成到微流控装置中,将夹心结构的肽-硅纳米线基底命名为 Pe-SiNWS。

结果

Pe-SiNWS 表现出优异的捕获效率(95.6%)和高释放效率(92.6%)。通过使用 Pe-SiNWS 进行特异性捕获和生物释放,可以获得高纯度(28.5%)和高细胞活力(93.5%)的 CTCs。高纯度的 CTCs 有助于精确快速的生物学分析,在 16 名胰腺癌患者中检测到了 5 种 KRAS 突变,而在健康供体中则没有检测到。

结论

结果表明,我们的新策略可以同时实现 CTC 的有效捕获、轻微损伤释放和精确分析。成功的临床应用表明,我们的工作有望为 CTC 微流控装置的设计开辟新的机会。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d9d8/6307685/44e14c7858ee/ijn-14-205Fig5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d9d8/6307685/697a0f17550e/ijn-14-205Fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d9d8/6307685/268cb3d1e746/ijn-14-205Fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d9d8/6307685/291ca1101915/ijn-14-205Fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d9d8/6307685/e8129671efef/ijn-14-205Fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d9d8/6307685/44e14c7858ee/ijn-14-205Fig5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d9d8/6307685/697a0f17550e/ijn-14-205Fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d9d8/6307685/268cb3d1e746/ijn-14-205Fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d9d8/6307685/291ca1101915/ijn-14-205Fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d9d8/6307685/e8129671efef/ijn-14-205Fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d9d8/6307685/44e14c7858ee/ijn-14-205Fig5.jpg

相似文献

1
Capture and biological release of circulating tumor cells in pancreatic cancer based on peptide-functionalized silicon nanowire substrate.基于肽功能化硅纳米线基底的胰腺癌循环肿瘤细胞捕获和生物释放。
Int J Nanomedicine. 2018 Dec 24;14:205-214. doi: 10.2147/IJN.S187892. eCollection 2019.
2
High purity microfluidic sorting and in situ inactivation of circulating tumor cells based on multifunctional magnetic composites.基于多功能磁性复合材料的高纯度微流控分选和循环肿瘤细胞的原位灭活。
Biomaterials. 2017 Sep;138:69-79. doi: 10.1016/j.biomaterials.2017.05.035. Epub 2017 May 22.
3
Aptamer-polymer functionalized silicon nanosubstrates for enhanced recovered circulating tumor cell viability and in vitro chemosensitivity testing.用于增强回收循环肿瘤细胞活力和体外化学敏感性测试的适体-聚合物功能化硅纳米底物
Int J Nanomedicine. 2016 May 18;11:2133-46. doi: 10.2147/IJN.S103569. eCollection 2016.
4
Simultaneous isolation and detection of circulating tumor cells with a microfluidic silicon-nanowire-array integrated with magnetic upconversion nanoprobes.采用集成有磁性上转换纳米探针的微流控硅纳米线阵列同时分离和检测循环肿瘤细胞。
Biomaterials. 2015 Jun;54:55-62. doi: 10.1016/j.biomaterials.2015.03.004. Epub 2015 Apr 1.
5
In Situ Detection and Quantification of AR-V7, AR-FL, PSA, and Point Mutations in Circulating Tumor Cells.循环肿瘤细胞中 AR-V7、AR-FL、PSA 及点突变的原位检测与定量
Clin Chem. 2018 Mar;64(3):536-546. doi: 10.1373/clinchem.2017.281295. Epub 2018 Jan 4.
6
Circulating tumor cells found in patients with localized and advanced pancreatic cancer.在局部和晚期胰腺癌患者中发现的循环肿瘤细胞。
Pancreas. 2015 May;44(4):547-50. doi: 10.1097/MPA.0000000000000324.
7
Microfluidic-Based Enrichment and Retrieval of Circulating Tumor Cells for RT-PCR Analysis.基于微流控技术的循环肿瘤细胞富集与提取用于逆转录聚合酶链反应分析
Methods Mol Biol. 2017;1634:55-64. doi: 10.1007/978-1-4939-7144-2_4.
8
Capture, release and culture of circulating tumor cells from pancreatic cancer patients using an enhanced mixing chip.使用增强混合芯片从胰腺癌患者中捕获、释放和培养循环肿瘤细胞。
Lab Chip. 2014 Jan 7;14(1):89-98. doi: 10.1039/c3lc51017d. Epub 2013 Nov 13.
9
Drug response of captured BT20 cells and evaluation of circulating tumor cells on a silicon nanowire platform.硅纳米线平台上捕获的 BT20 细胞的药物反应和循环肿瘤细胞的评估。
Biosens Bioelectron. 2015 May 15;67:370-8. doi: 10.1016/j.bios.2014.08.057. Epub 2014 Aug 27.
10
ZnO nanowire-integrated bio-microchips for specific capture and non-destructive release of circulating tumor cells.氧化锌纳米线集成的生物微芯片,用于特异性捕获和无损释放循环肿瘤细胞。
Nanoscale. 2020 Jan 23;12(3):1455-1463. doi: 10.1039/c9nr07349c.

引用本文的文献

1
Peptide-Functionalized Nanomedicine: Advancements in Drug Delivery, Diagnostics, and Biomedical Applications.肽功能化纳米药物:药物递送、诊断及生物医学应用的进展
Molecules. 2025 Mar 31;30(7):1572. doi: 10.3390/molecules30071572.
2
Circulating tumor cell markers for early detection and drug resistance assessment through liquid biopsy.通过液体活检用于早期检测和耐药性评估的循环肿瘤细胞标志物。
Front Oncol. 2025 Apr 7;15:1494723. doi: 10.3389/fonc.2025.1494723. eCollection 2025.
3
Nanomaterial-based detection of circulating tumor cells and circulating cancer stem cells for cancer immunotherapy.

本文引用的文献

1
Label-Free Quantification of Intracellular Mitochondrial Dynamics Using Dielectrophoresis.无标记定量检测介电泳法中的细胞内线粒体动力学。
Anal Chem. 2017 Jun 6;89(11):5757-5764. doi: 10.1021/acs.analchem.6b04666. Epub 2017 May 15.
2
Enhanced Isolation and Release of Circulating Tumor Cells Using Nanoparticle Binding and Ligand Exchange in a Microfluidic Chip.利用纳米颗粒结合和配体交换在微流控芯片中增强循环肿瘤细胞的分离和释放。
J Am Chem Soc. 2017 Feb 22;139(7):2741-2749. doi: 10.1021/jacs.6b12236. Epub 2017 Feb 9.
3
Optical Properties of Silicon Nanowires Fabricated by Environment-Friendly Chemistry.
基于纳米材料的循环肿瘤细胞和循环癌干细胞检测用于癌症免疫治疗。
Nano Converg. 2024 Dec 13;11(1):56. doi: 10.1186/s40580-024-00466-x.
4
Microfluidic biosensors for biomarker detection in body fluids: a key approach for early cancer diagnosis.用于检测体液中生物标志物的微流控生物传感器:早期癌症诊断的关键方法。
Biomark Res. 2024 Dec 5;12(1):153. doi: 10.1186/s40364-024-00697-4.
5
Recent advances in micro-/nanostructure array integrated microfluidic devices for efficient separation of circulating tumor cells.用于高效分离循环肿瘤细胞的微/纳米结构阵列集成微流控装置的最新进展。
RSC Adv. 2022 Dec 6;12(54):34892-34903. doi: 10.1039/d2ra06339e.
6
Detection of circulating tumor cells: Advances and critical concerns.循环肿瘤细胞的检测:进展与关键问题
Oncol Lett. 2021 May;21(5):422. doi: 10.3892/ol.2021.12683. Epub 2021 Mar 29.
7
Nanotechnology-Assisted Isolation and Analysis of Circulating Tumor Cells on Microfluidic Devices.微流控装置上纳米技术辅助的循环肿瘤细胞分离与分析
Micromachines (Basel). 2020 Aug 14;11(8):774. doi: 10.3390/mi11080774.
通过环境友好化学制备的硅纳米线的光学性质
Nanoscale Res Lett. 2016 Dec;11(1):357. doi: 10.1186/s11671-016-1568-5. Epub 2016 Aug 9.
4
Combined cell surface carbonic anhydrase 9 and CD147 antigens enable high-efficiency capture of circulating tumor cells in clear cell renal cell carcinoma patients.联合细胞表面碳酸酐酶9和CD147抗原可高效捕获透明细胞肾细胞癌患者的循环肿瘤细胞。
Oncotarget. 2016 Sep 13;7(37):59877-59891. doi: 10.18632/oncotarget.10979.
5
Aptamer-polymer functionalized silicon nanosubstrates for enhanced recovered circulating tumor cell viability and in vitro chemosensitivity testing.用于增强回收循环肿瘤细胞活力和体外化学敏感性测试的适体-聚合物功能化硅纳米底物
Int J Nanomedicine. 2016 May 18;11:2133-46. doi: 10.2147/IJN.S103569. eCollection 2016.
6
Capturing Cancer: Emerging Microfluidic Technologies for the Capture and Characterization of Circulating Tumor Cells.捕捉癌症:新兴的微流控技术用于捕获和表征循环肿瘤细胞。
Small. 2015 Aug 26;11(32):3850-72. doi: 10.1002/smll.201403658. Epub 2015 May 20.
7
A microfluidic device for label-free, physical capture of circulating tumor cell clusters.一种用于无标记物理捕获循环肿瘤细胞簇的微流控装置。
Nat Methods. 2015 Jul;12(7):685-91. doi: 10.1038/nmeth.3404. Epub 2015 May 18.
8
Tunable nanostructured coating for the capture and selective release of viable circulating tumor cells.用于捕获和选择性释放活循环肿瘤细胞的可调谐纳米结构涂层。
Adv Mater. 2015 Mar 4;27(9):1593-9. doi: 10.1002/adma.201404677. Epub 2015 Jan 15.
9
Pancreatic adenocarcinoma.胰腺腺癌
N Engl J Med. 2014 Sep 11;371(11):1039-49. doi: 10.1056/NEJMra1404198.
10
Peptide-functionalized nanoparticles for selective targeting of pancreatic tumor.肽功能化纳米颗粒用于选择性靶向胰腺肿瘤。
J Control Release. 2014 Oct 28;192:29-39. doi: 10.1016/j.jconrel.2014.06.039. Epub 2014 Jun 28.